1989
DOI: 10.1016/0360-3016(89)90941-3
|View full text |Cite
|
Sign up to set email alerts
|

Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

8
329
1
4

Year Published

1997
1997
2011
2011

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 723 publications
(342 citation statements)
references
References 3 publications
8
329
1
4
Order By: Relevance
“…These findings are consistent with prior studies that have shown that the vast majority of recurrences occur within 2 cm of the original tumor site [10,30,31] or "in field" (more than 80% of the tumor recurrence residing within the prescription isodose) [32]. The results summarized in Table 3 show that the increased CE, as a presumed sign of tumor recurrence, occurred both within and beyond the prescribed dose of 60 Gy.…”
Section: Discussionsupporting
confidence: 90%
See 1 more Smart Citation
“…These findings are consistent with prior studies that have shown that the vast majority of recurrences occur within 2 cm of the original tumor site [10,30,31] or "in field" (more than 80% of the tumor recurrence residing within the prescription isodose) [32]. The results summarized in Table 3 show that the increased CE, as a presumed sign of tumor recurrence, occurred both within and beyond the prescribed dose of 60 Gy.…”
Section: Discussionsupporting
confidence: 90%
“…Computerized tomography (CT) and magnetic resonance imaging (MRI) are currently used to delineate the target volume for high grade gliomas with MRI providing superior soft tissue contrast [5][6][7]. Target volumes for 3D conformal radiation therapy (3D-CRT) are defined to cover the Gadolinium contrast enhancing region on T1-weighted images obtained from MRI with a uniform margin of 1 to 4 cm [1,[8][9][10] and/or the area of hyperintense lesion on T2-weighted MRI enlarged by several centimeters [11,12].…”
Section: Introductionmentioning
confidence: 99%
“…The predominant site of tumor recurrence following both surgery and radiation is local. 2 As most tumor recurrences are within the initial tumor bed, direct injection of attenuated oncolytic viruses such as herpes simplex virus-1 (HSV-1) has been proposed as an adjuvant treatment and utilized in Phase I clinical trials for high-grade gliomas. [3][4][5][6][7] HSV-1 is a double-stranded DNA virus expressing its genes in a sequential cascade of immediate-early (a), early (b), and late (g) genes.…”
Section: Introductionmentioning
confidence: 99%
“…More than 90% of tumors recur within the initial tumor site. 1,2 Among novel approaches to treatment of malignant gliomas are genetically engineered viruses which themselves are cytocidal or capable of delivering genes whose products render the cells susceptible to cytotoxic agents. Assessment of the capacity of herpes simplex viruses (HSV) for treatment of malignant gliomas has taken two approaches.…”
Section: Introductionmentioning
confidence: 99%